trifluoperazine hydrochloride has been researched along with triparanol in 1 studies
*Triparanol: Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts. [MeSH]
*Triparanol: Antilipemic agent with high ophthalmic toxicity. According to Merck Index, 11th ed, the compound was withdrawn from the market in 1962 because of its association with the formation of irreversible cataracts. [MeSH]
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (100.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bartl, N; Bracher, F; Giera, M; Hemmers, S; Körner, A; Mirakaj, V; Müller, C; Plodek, A | 1 |
1 other study(ies) available for trifluoperazine hydrochloride and triparanol
| Article | Year |
|---|---|
New chemotype of selective and potent inhibitors of human delta 24-dehydrocholesterol reductase.
Topics: Animals; Desmosterol; Enzyme Inhibitors; HL-60 Cells; Humans; Inhibitory Concentration 50; Mice; Nerve Tissue Proteins; Oxidoreductases Acting on CH-CH Group Donors; Spectrum Analysis | 2017 |